期刊文献+

重组人肿瘤坏死因子调节端粒酶活性的体外研究 被引量:6

Regulation of the telomerase activity by recombinant human tumor necrosis factor in vitro
原文传递
导出
摘要 目的 研究重组人肿瘤坏死因子 (rhTNF)对端粒酶活性的调节作用。方法 将不同浓度rhTNF加入肝癌细胞株HepG2和HepG1 6细胞 ,以TRAP ELISA方法测定其端粒酶活性 ;采用Lipofect脂质体转染法将携带端粒酶催化亚单位—端粒酶逆转录酶 (hTERT)启动子的质粒转染至肝癌细胞株HepG2细胞 ,2h后加入不同浓度的rhTNF ,孵育 48h后 ,分别检测其报告基因萤虫素酶活性。 结果 在 10~ 10 0 0IU/ml浓度范围内 ,rhTNF可抑制端粒酶活性 ,同时在该浓度范围内 ,rhTNF可显著抑制hTERT启动子的表达 ,其抑制作用与rhTNF剂量呈正相关。结论 rhTNF杀伤肿瘤细胞的机制可能与其抑制hTERT的表达有关。 Objective To investigate the effect of recombinant human tumor necrosis factor (rhTNF) on telomerase activity in hepatoma cell line HepG2 cells and HepG1 6 cells. Methods TRAP ELISA method was used to determine the telomerase activity in HepG2 and HepG1 6 cells which were treated by different concentrations of rhTNF; plasmid which had been inserted 800 bp of the hTERT promoter was transiently transfected into HepG2 cells by Lipofect, and different concentrations of rhTNF were added into culture media 2 hours later, then the activity of the hTERT promoter was tested 48 hours after transfection. Results The telomerase activity of HepG2 was suppressed by rhTNF in a dose dependent manner. The expression of hTERT promoter was inhibited linearly with the dose of rhTNF within the range of 10~1 000 IU/ml. Conclusions Above results suggest that the anti tumor activity of rhTNF may attribute to its inhibitory effect on hTERT promoter expression.
出处 《中华消化杂志》 CAS CSCD 北大核心 2001年第3期156-158,共3页 Chinese Journal of Digestion
基金 上海市青年科技启明星计划资助!项目 (0 0QB14 0 5 4)
关键词 重组人肿瘤坏死因子 端粒酶逆转录酶 基因调控 肿瘤 抑制作用 Recombinant human tumor necrosis factor (rhTNF) Human telomerase reverse transcriptase (hTERT) Gene regulation
  • 相关文献

参考文献6

  • 1Saito Y,Anticancer Res,1999年,19卷,1069页
  • 2Akiyama M,Cancer Lett,1999年,142卷,23页
  • 3Dome J S,Curr Opin Oncol,1999年,11卷,58页
  • 4Wu K J,Nat Genet,1999年,21卷,220页
  • 5Meyerson M,Cell,1997年,90卷,785页
  • 6谢渭芬,免疫学杂志,1995年,11卷,116页

同被引文献57

  • 1潘启超,田晖.多种中药单体逆转肿瘤多药耐药性[J].科学通报,1995,40(20):1901-1904. 被引量:69
  • 2王田,邱学德,黄杰,刘乔保,肖民辉,杨晓华.茶多酚对膀胱肿瘤细胞端粒酶活性的影响[J].现代泌尿外科杂志,2005,10(6):314-316. 被引量:6
  • 3王四旺,谢艳华.安替可胶囊对人癌细胞抑制的作用[J].第四军医大学学报,1996,17(4):283-286. 被引量:10
  • 4蔡雄,王国俊,瞿瑶,樊成辉,张瑞祺,徐文胜.苦参素注射液治疗慢性乙型肝炎临床疗效分析[J].第二军医大学学报,1997,18(1):47-49. 被引量:345
  • 5Ahmad N, Cheng P, Mukhtar H, et al. Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate.Biochem Biophys Res Commun 2000 ; 275 (2) : 328--334.
  • 6Liberto M, Cobrinik D. Growth factor-dependent induction of p21 (CIP1) by the green tea polyphenol, epigallocatechin gallate. Cancer Lett 2000; 154(2) :151--161.
  • 7Jing L, Nakaya K, Yoshida T, et al. Induction by bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macmphage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers. Cancer Res 1992; 52(17) :1193--1198.
  • 8Zhang LP, Jiang JK, Tam JW, et al. Effects of matrine on proliferation and differentiation in K-562 cell. Leuk Res 2001;25(9):793--800.
  • 9Watabe M, Masuda Y, Nakajo S, et al. The cooperative interaction of two different signaling pathways in response to bufalin induces apoptosis in human leukemia U937 Cells. J Biol Chem 1996;271(24):14067--14071.
  • 10Watabe M, Ito K, Masuda Y, et al. Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells. Oncogene 1998; 16(6) : 779--789.

引证文献6

二级引证文献219

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部